{
    "eid": "2-s2.0-85079894620",
    "title": "Association between the phenotype and genotype of isoniazid resistance among Mycobacterium tuberculosis isolates in Thailand",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Gene mutation",
        "Isoniazid",
        "Line probe assay",
        "Minimal inhibitory concentration",
        "Tuberculosis"
    ],
    "authors": [
        "Ratchanu Charoenpak",
        "Wichai Santimaleeworagun",
        "Gompol Suwanpimolkul",
        "Weerawat Manosuthi",
        "Paweena Kongsanan",
        "Suthidee Petsong",
        "Chankit Puttilerpong"
    ],
    "citedby-count": 9,
    "ref-count": 30,
    "ref-list": [
        "Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: A multicentre cohort study",
        "Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis",
        "Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations",
        "The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan",
        "Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan",
        "Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis",
        "Resistance to isoniazid and ethionamide in Mycobacterium tuberculosis: Genes, mutations, and causalities",
        "Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan",
        "A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis",
        "Intermediate susceptibility dose-dependent breakpoints for high-dose rifampin, isoniazid, and pyrazinamide treatment in multidrug-resistant tuberculosis programs",
        "Susceptibility testing of mycobacteria, norcardia spp., and other arerobic actinomycetes",
        "Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand",
        "Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand",
        "Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: A systematic review",
        "Whole genome sequencing, analyses of drug resistance-conferring mutations, and correlation with transmission of Mycobacterium tuberculosis carrying katG-S315T in Hanoi, Vietnam",
        "Genotypic characterization of multi-drug-resistant Mycobacterium tuberculosis isolates in Myanmar",
        "Identification and characterization of genetic determinants of isoniazid and rifampicin resistance in Mycobacterium tuberculosis in Southern India",
        "Significance of coexisting mutations on determination of the degree of isoniazid resistance in Mycobacterium tuberculosis strains",
        "Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in Mycobacterium tuberculosis strains from Romania",
        "Diagnostic accuracy and usefulness of the genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? A cross-sectional study",
        "Isoniazid resistance in Mycobacterium tuberculosis is a heterogeneous phenotype composed of overlapping MIC distributions with different underlying resistance mechanisms",
        "Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests",
        "Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands",
        "In vitro activity and MIC of sitafloxacin against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis isolated in Thailand",
        "Bureau of tuberculosis, Department of disease control. National Tuberculosis Control Programme Guideline, Thailand, 2018",
        "Effect of mycobacterial drug resistance patterns on patients\u2019 survival: A cohort study in Thailand"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60031780",
            "affilname": "Thai Red Cross Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60018809",
            "affilname": "Silpakorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018809",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "60015728",
            "affilname": "Thailand Ministry of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "116677307",
            "affilname": "College of Pharmacotherapy Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/116677307",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Doctor Kasem Pangsrivongse Foundation",
        "Chulalongkorn University"
    ]
}